臨床醫學總監

公司簡介本康生物制藥（深圳）有限公司（BenHealth）是專業從事生物制藥和細胞治療創新工具與技術解決方案的公司。依托公司在蛋白質工程研究的多年積累，儲備了大量有望改造和提升細胞免疫治療技術的工具，涵蓋創新型雙特異性抗體藥物的開發、細胞培養方案及細胞表型控制、基于磁珠的細胞分離技術以及細胞檢測等諸多方面。此外，針對AMT/AMNK細胞靶向修飾、靶向CTL的DC技術及TIL研究等領域，本康生物也已建立起一系列先進研發平臺。本康生物將不斷地創新，提高輸出產品與技術的品質，讓免疫治療變得精準化、個體化、成本低廉、簡單易行。我們的目標是使癌癥由絕癥變為慢性病，最終能夠被治愈。Company?introductionBenHealth?Biopharmaceutical?(Shenzhen)?Co.?Ltd?is?a?company?specialized?in?biopharmaceutics?and?cell?therapy?tools?and?technology?innovations.?Based?on?the?past?research?on?protein?engineering,?we?have?i***ented?numerous?lucrative?tools?for?cell?immunotherapy?technology?and?engineering,?including?but?not?limited?to?the?development?of?innovative?bispecific?antibody?drugs,?cell?cultivating?protocols,?cell?phenotype?controls,?magnetic-particle-based?cell?division?methods?and?cell?detections.?Besides,?focusing?on?different?research?fields?such?as?AMT/AMNK?cell?targeting?embellishment,?CTL-targeted?DC?technology,?TIL?research?and?so?on,?we?have?built?a?series?of?forefront?research?platforms.?BenHealth?will?continue?to?be?creative?and?try?to?improve?the?quality?of?our?products?and?technology,?thus?the?immune?therapy?will?be?specialized?and?personalized,?which?will?also?be?moneysaving?and?foolproof.?Our?aim?is?to?change?cancer?from?a?lethal?disease?to?a?curative?one.